Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Inflammatory Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: doxorubicin hydrochloride|DRUG: cyclophosphamide|DRUG: tipifarnib|BIOLOGICAL: filgrastim|PROCEDURE: therapeutic conventional surgery|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)